- AdventHealth Research Institute
NKGen Biotech, Inc., a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel, expanded enhanced autologous NK cell therapy, for the treatment of moderate Alzheimer’s disease (NCT06189963). In addition to Dr. Fletcher’s appointment as National PI, NKGen is pleased to announce AdventHealth Research Institute, Neuroscience Research in Orlando will be the first clinical site on the East Coast with the intent of enrolling moderate stage Alzheimer’s Disease (“AD”) patients in the very near term.
Read more about the announcement and the study by clicking the button below.
Recent News
Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of...
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health
Results From IGNITE Research Study Published in the Medical Journal "Age and Ageing"
“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
The AdventHealth Cancer Institute has been recognized in Becker's Hospital Review as one of the top 100 hospitals and health systems in the country for its excellence in oncology.
Dr. Wassim McHayleh featured in article about breast cancer research.
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.
Dr. Patricia Robinson has received has been named one of 50 Most Influential Clinical Executives in 2024 by Modern Healthcare.
Dr. Daryl Osbahr serves as team orthopedic surgeon and team physician for U.S. Men's National Soccer Team.
and helps the team hit health goals during summer events.